return to web version
print this page
Sales Manager, Contract Services
180 Attwell Drive, Suite 360
Toronto, Ontario, Canada
M9W 6A9
Tel: (416) 675-8290
Fax: (416) 675-8301
Email: contractsales@cangene.com
Cangene offers its customers considerable experience in developing biopharmaceutical processes for plasma-derived and recombinant proteins (bacterial and mammalian). For plasma-derived proteins, Cangene can apply leading-edge process technologies related to purification and viral inactivation that have been employed successfully in several commercial products. For recombinant proteins, Cangene can provide fermentation and purification-process development services designed to generate bulk product with the level of purity required for clinical and commercial use.
Cangene also has experience providing its customers with finished product development services for parenteral products, including formulation development, and lyophilization-cycle development and optimization. Cangene has applied its expertise to developing a variety of products including plasma-derived and recombinant proteins, and antisense oligonucleotides.
Cangene has a proprietary expression system, Cangenus®, which can be used for recombinant proteins that are difficult to express in other systems. It is a bacterial expression system that secretes bioactive proteins in soluble form with expression levels up to the gram per liter range. Cangene offers expression feasibility studies for customer products-if these are successful, process development and scale-up to the manufacturing scale required for clinical studies can follow.
ISO 9001- 2008 Certified